Filter
248
Filtered Results: 248
Text search:
Kaiser,
M.
Featured
Recommendations
20
New Publications
29
Language
Document type
No document type
102
Studies & Reports
72
Guidelines
45
Manuals
17
Strategic & Response Plan
5
Training Material
4
Fact sheets
3
Countries / Regions
Global
16
Africa
7
Germany
7
Tanzania
6
Brazil
6
Latin America and the Carribbean
5
Kenya
4
Malawi
4
Zimbabwe
4
Mozambique
4
Uganda
4
Russia
4
Lesotho
3
Haiti
3
Congo, Democratic Republic of
3
Western and Central Europe
3
Bangladesh
3
South Africa
3
Namibia
3
South Sudan
3
Cameroon
2
Senegal
2
Philippines
2
West and Central Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Portugal
2
Indonesia
2
Nepal
1
Colombia
1
Sierra Leone
1
Rwanda
1
Chile
1
Syria
1
Burkina Faso
1
Malaysia
1
Guinea
1
Italy
1
Asia
1
Western Pacific Region
1
France
1
East and Southern Africa
1
Latvia
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Vietnam
1
Yemen
1
Central African Republic
1
Ethiopia
1
Angola
1
Botswana
1
Zambia
1
Ecuador
1
India
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
62
Clinical Guidelines
27
Public Health
11
Pharmacy & Technologies
8
Women & Child Health
6
Key Resources
4
Capacity Building
3
Toolboxes
COVID-19
39
HIV
36
Mental Health
20
TB
18
NTDs
15
Planetary Health
14
Health Financing Toolbox
9
Zika
8
Rapid Response
6
Caregiver
6
Global Health Education
5
Refugee
4
Disability
4
NCDs
4
AMR
4
Pharmacy
2
Cholera
1
Social Ethics
1
The Arid and Semi-Arid lands (ASAL) constitute about 80% (467,200 sq. km) of Kenya’s total land mass and is grouped into geographical zones including the Savannah covering most of the North- eastern and South-eastern parts, the Coastal region, the North Rift Valley, the Highlands and the Lake Vict...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
The sub-Saharan African region, carries 90% of the over 250 million cases of schistosomiasis occurring worldwide. In this region, after Nigeria, Tanzania is second country having the highest cases of schistosomiasis and approximately 51.5%0 of the Tanzanian population is either exposed or live in ar...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions of Af...
Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u...
Safe drinking-water management must consider drinking-water quality, acceptability and quantity in the context of public health protection. In this manual, the term “safety” encompasses these three elements. Although the principles in this manual can be broadly applied to all types of drinking-w...
MOBILISIERUNG INLÄNDISCHER ÖFFENTLICHER RESSOURCEN FÜR GESUNDHEIT
